Follow
Metabolic imaging
Metabolic imaging observes changes in metabolic pathways to help detect medical conditions. In addition to diagnosis, metabolic imaging can be used to evaluate therapeutic response to assist in treatment management. Metabolic imaging can be done with a variety of non-invasive techniques including positron emission tomography (PET) scans and magnetic resonance imaging (MRI).
SEP 08, 2021 | 12:00 AM
Influenza viruses represent a significant burden to human health. In order to limit respiratory viral disease, new approaches that can prevent viral infection and spread are needed. We have...
AUG 26, 2021 | 7:00 AM
Date: August 26, 2021 Time: 7:00am (PDT), 10:00am (EDT) Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with rising incidence and a remarkable resistance to current therapies. In t...
AUG 25, 2021 | 12:00 AM
Learning Objectives: 1. Explore the neuroinvasive potential of SARS-CoV-2 2. Learn about possible consequences of neuroinvasion of SARS-CoV-2 3. Identify neuroimmune responses against SARS-C...
JUL 28, 2021 | 8:00 AM
Date: July 28, 2021 Time: 8:00am PDT Breast cancer is the most common form of cancer in women. It is estimated that 1 out of 8 women in the US will develop invasive breast cancer during her...
JUN 02, 2021 | 12:00 AM
Despite the promising results with current approved immunotherapies, all patients do not have the same level of response, and recent efforts have focused on understanding and avoiding immuno...
MAY 06, 2021 | 7:00 AM
Date: May 6, 2021 Time: 7:00am PDT, 10:00am EDT, 4:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal changes in cultivati...
APR 22, 2021 | 9:00 AM
(Adapted from a DPYD verification document written by Hannah Stevens, Trainee Clinical Scientist) 5-Fluorouracil (5-FU) and capecitabine are fluoropyrimidine chemotherapies that are used to...
APR 22, 2021 | 12:00 AM
5-fluorouracil (5-FU) and its oral analog capecitabine are fluoropyrimidine chemotherapy agents used in several solid tumors. Approximately 5% of patients inherit diminished or null activity...
APR 22, 2021 | 12:00 AM
Phenoconversion is a mismatch between an individual’s genotype-based prediction of a drug metabolism and its true capacity. In other words, there is a mismatch between the clinically o...
APR 20, 2021 | 7:30 AM
C.E. CREDITS
Structural variants (SVs) are essential in human evolution and genetic disease but remain understudied. This is especially the case for non-Caucasian ethnicities. We report, for the first ti...
